Evaluating the impact of ongoing treatment with high-concentration capsaicin topical system on pain, sleep, quality of life, and affective distress in patients with painful diabetic peripheral neuropathy of the hands: Findings from the real-world CASPAR study

Überall MA, Quandel T, Engelen S, Freitas R, Garcia Guerra L, Allen S, Eerdekens M, Marotta K

American Society of Pain & Neuroscience (ASPN) Conference

See event page
Link copied successfully!

The content includes information pertaining to products or uses that have not received approval from the US Food and Drug administration. Averitas Pharma does not recommend the use of its products outside the approved prescribing information. For full prescribing information, including indications, contraindications, warnings, precautions, and adverse events, please refer to the approved product labeling.

REF-45842

Related content

See all congress contributions

DPN, diabetic peripheral neuropathy; HCCTS, high-concentration capsaicin topical system; PDPN, painful diabetic peripheral neuropathy.

N/A-US-01-25-0012 | July 2025